Experimental beta-alaninuria induced by (aminooxy)acetate.

Area of Science:

• Biochemistry
• Physiology
• Toxicology

Background:

• Hyper-beta-alaninemia is a condition characterized by elevated levels of beta-alanine.
• The precise mechanisms underlying hyper-beta-alaninemia are not fully understood.
• Aminotransferase enzymes play crucial roles in amino acid metabolism.

Purpose of the Study:

• To investigate the pathogenesis of hyper-beta-alaninemia.
• To determine the role of beta-alanine transaminase in this condition.
• To establish an experimental model for studying beta-alaninuria.

Main Methods:

• Experimental beta-alaninuria was induced in rats via subcutaneous injection of (aminooxy)acetate (AOA).
• Urine and tissue samples were analyzed using chromatographic and mass spectrometric techniques.
• Changes in beta-alanine (BALA), beta-aminoisobutyric acid (BAIBA), and gamma-aminobutyric acid (GABA) levels were quantified.

Main Results:

• AOA injection led to a significant increase in BALA excretion (27-fold).
• Simultaneous increases in BAIBA (13-fold) and GABA (9-fold) excretion were observed.
• Tissue analysis revealed elevated BALA levels in the liver and kidney, and increased GABA in the brain.

Conclusions:

• The study indicates that beta-alanine transaminase is involved in the development of hyper-beta-alaninemia.
• AOA serves as an effective agent for inducing experimental beta-alaninuria and associated metabolic changes.
• These findings provide insights into the metabolic pathways contributing to beta-alanine dysregulation.